Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by AMAN U BUZDAR and GEORGE R BLUMENSCHEIN.
AMAN U BUZDAR
Connection Strength
1.360
GEORGE R BLUMENSCHEIN
  1. Early and delayed clinical cardiotoxicity of doxorubicin. Cancer. 1985 Jun 15; 55(12):2761-5.
    View in: PubMed
    Score: 0.065
  2. Breast cancer. Cancer Treat Rev. 1984 Dec; 11(4):315-9.
    View in: PubMed
    Score: 0.063
  3. Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer. Recent Results Cancer Res. 1984; 96:141-7.
    View in: PubMed
    Score: 0.059
  4. Hematologic adverse effects of aminoglutethimide. Ann Intern Med. 1984 Jan; 100(1):159.
    View in: PubMed
    Score: 0.059
  5. Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen. Cancer. 1982 Nov 01; 50(9):1708-12.
    View in: PubMed
    Score: 0.054
  6. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience. Cancer Res. 1982 Aug; 42(8 Suppl):3448s-3450s.
    View in: PubMed
    Score: 0.053
  7. Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens. Cancer. 1981 Jun 15; 47(12):2798-802.
    View in: PubMed
    Score: 0.049
  8. Management of inflammatory carcinoma of breast with combined modality approach - an update. Cancer. 1981 Jun 01; 47(11):2537-42.
    View in: PubMed
    Score: 0.049
  9. Pulmonary toxicity of mitomycin. Cancer. 1980 Jan 15; 45(2):236-44.
    View in: PubMed
    Score: 0.045
  10. Drug-associated cardiotoxicity. JAMA. 1979 May 04; 241(18):1893.
    View in: PubMed
    Score: 0.043
  11. Adriamycin and mitomycin C: possible synergistic cardiotoxicity. Cancer Treat Rep. 1978 Jul; 62(7):1005-8.
    View in: PubMed
    Score: 0.040
  12. High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study. J Clin Oncol. 1987 Feb; 5(2):178-84.
    View in: PubMed
    Score: 0.018
  13. Second neoplasms after adjuvant chemotherapy for operable breast cancer. Am J Clin Oncol. 1986 Jun; 9(3):269-75.
    View in: PubMed
    Score: 0.017
  14. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res. 1986 May; 46(5):2578-81.
    View in: PubMed
    Score: 0.017
  15. Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy. Cancer. 1985 Nov 15; 56(10):2381-4.
    View in: PubMed
    Score: 0.017
  16. Five-day continuous-infusion vinblastine in the treatment of breast cancer. Cancer. 1985 Jul 15; 56(2):225-9.
    View in: PubMed
    Score: 0.016
  17. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma. Cancer. 1985 Jan 15; 55(2):337-40.
    View in: PubMed
    Score: 0.016
  18. High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer. Oncology. 1985; 42(5):273-4.
    View in: PubMed
    Score: 0.016
  19. Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer. Breast Cancer Res Treat. 1985; 5(3):321-6.
    View in: PubMed
    Score: 0.016
  20. Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer. Semin Oncol. 1984 Sep; 11(3 Suppl 1):28-31.
    View in: PubMed
    Score: 0.015
  21. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone. Cancer Treat Rep. 1984 Jul-Aug; 68(7-8):1039-41.
    View in: PubMed
    Score: 0.015
  22. Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate. J Surg Oncol. 1984 Jul; 26(3):205-7.
    View in: PubMed
    Score: 0.015
  23. Radiation-induced breast cancer. Arch Intern Med. 1984 Jun; 144(6):1217-9.
    View in: PubMed
    Score: 0.015
  24. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone. Cancer. 1984 May 01; 53(9):1841-4.
    View in: PubMed
    Score: 0.015
  25. Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio. Cancer. 1984 May 01; 53(9):1836-40.
    View in: PubMed
    Score: 0.015
  26. Tumor-associated fever in breast cancer. Cancer. 1984 Apr 01; 53(7):1596-9.
    View in: PubMed
    Score: 0.015
  27. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial. Cancer. 1984 Feb 01; 53(3):384-9.
    View in: PubMed
    Score: 0.015
  28. Combined modality approach in breast cancer with isolated or multiple metastases. Am J Clin Oncol. 1984 Feb; 7(1):45-50.
    View in: PubMed
    Score: 0.015
  29. FAC + BCG as adjuvant therapy in breast cancer: an 8-year update. Recent Results Cancer Res. 1984; 96:129-32.
    View in: PubMed
    Score: 0.015
  30. Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol. 1983 Dec; 1(12):776-86.
    View in: PubMed
    Score: 0.015
  31. Benign versus malignant hepatic lesions. A diagnostic dilemma with breast cancer patients. Cancer. 1983 Oct 01; 52(7):1308-11.
    View in: PubMed
    Score: 0.014
  32. Cranial nerve palsies in metastatic breast cancer due to osseous metastasis without intracranial involvement. Cancer. 1983 Jul 01; 52(1):180-4.
    View in: PubMed
    Score: 0.014
  33. Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer. J Surg Oncol. 1983 May; 23(1):32-4.
    View in: PubMed
    Score: 0.014
  34. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy. Int J Radiat Oncol Biol Phys. 1983 May; 9(5):643-50.
    View in: PubMed
    Score: 0.014
  35. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA. 1983 Apr 08; 249(14):1881-6.
    View in: PubMed
    Score: 0.014
  36. Hormonal therapy for metastatic male breast cancer. Arch Intern Med. 1983 Feb; 143(2):237-40.
    View in: PubMed
    Score: 0.014
  37. AMSA and peptichemio in the treatment of advances metastatic breast cancer: a phase II study. Am J Clin Oncol. 1982 Aug; 5(4):383-7.
    View in: PubMed
    Score: 0.013
  38. Peptichemio versus melphalan (L-PAM) in advanced breast cancer. Cancer. 1982 May 01; 49(9):1767-70.
    View in: PubMed
    Score: 0.013
  39. Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen. Cancer. 1982 Feb 01; 49(3):413-7.
    View in: PubMed
    Score: 0.013
  40. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Treat. 1982; 2(2):163-9.
    View in: PubMed
    Score: 0.013
  41. Combination chemotherapy for breast cancer metastatic to bone marrow. Cancer. 1981 Jul 15; 48(2):227-32.
    View in: PubMed
    Score: 0.012
  42. Tamoxifen-induced hypercalcemia in breast cancer. Cancer. 1981 Jun 15; 47(12):2803-6.
    View in: PubMed
    Score: 0.012
  43. Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy. Cancer. 1980 Aug 01; 46(3):438-45.
    View in: PubMed
    Score: 0.012
  44. Causes of death in breast cancer: a clinicopathologic study. Cancer. 1980 Jul 01; 46(1):162-7.
    View in: PubMed
    Score: 0.012
  45. Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma. Cancer. 1980 Feb 15; 45(4):742-9.
    View in: PubMed
    Score: 0.011
  46. Immune-complex glomerulonephritis secondary to nonspecific immunotherapy. Cancer. 1980 Feb; 45(3):495-7.
    View in: PubMed
    Score: 0.011
  47. Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report. JAMA. 1979 Oct 05; 242(14):1509-13.
    View in: PubMed
    Score: 0.011
  48. Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy. JAMA. 1979 Jul 06; 242(1):49-52.
    View in: PubMed
    Score: 0.011
  49. Hormonal therapy with tamoxifen in male breast cancer. Cancer Treat Rep. 1979 Apr; 63(4):539-41.
    View in: PubMed
    Score: 0.011
  50. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer. Cancer Treat Rep. 1979 Jan; 63(1):115-20.
    View in: PubMed
    Score: 0.010
  51. Rubidazone in metastatic breast cancer. Cancer Treat Rep. 1979 Jan; 63(1):135-6.
    View in: PubMed
    Score: 0.010
  52. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED). J Surg Oncol. 1979; 12(1):27-40.
    View in: PubMed
    Score: 0.010
  53. Endobronchial metastasis from cancer of the breast. Chest. 1978 Sep; 74(3):319-20.
    View in: PubMed
    Score: 0.010
  54. Endobronchial metastases in breast carcinoma. West J Med. 1978 Sep; 129(3):177-80.
    View in: PubMed
    Score: 0.010
  55. Longitudinal nail banding associated with breast carcinoma unrelated to chemotherapy. Arch Intern Med. 1978 Aug; 138(8):1302-3.
    View in: PubMed
    Score: 0.010
  56. Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy. Cancer. 1978 Jun; 41(6):2084-7.
    View in: PubMed
    Score: 0.010
  57. Cerebromedullospinal disconnection after intraventricular methotrexate. South Med J. 1978 Apr; 71(4):476-7.
    View in: PubMed
    Score: 0.010
  58. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer. Cancer. 1978 Mar; 41(3):1064-75.
    View in: PubMed
    Score: 0.010
  59. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer. Cancer Treat Rep. 1978 Mar; 62(3):405-8.
    View in: PubMed
    Score: 0.010
  60. Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy. Cancer. 1978 Feb; 41(2):392-5.
    View in: PubMed
    Score: 0.010
  61. Adjuvant therapy of stage II, III breast cancer. Recent Results Cancer Res. 1978; 68:123-8.
    View in: PubMed
    Score: 0.010
  62. Chemotherapy with mitoxantrone in combination with continuous infusion vinblastine for metastatic breast cancer. Cancer. 1987 Oct 15; 60(8):1724-8.
    View in: PubMed
    Score: 0.005
  63. Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy. Cancer. 1987 Jun 15; 59(12):1992-9.
    View in: PubMed
    Score: 0.005
  64. Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study. J Clin Oncol. 1987 Mar; 5(3):354-64.
    View in: PubMed
    Score: 0.005
  65. A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer. Cancer Chemother Pharmacol. 1986; 18(2):157-61.
    View in: PubMed
    Score: 0.004
  66. Prediction of survival by degree of reactivity to BCG in patients with metastatic breast cancer. Dev Biol Stand. 1986; 58 ( Pt A):357-63.
    View in: PubMed
    Score: 0.004
  67. Phase II study of AMSA and doxorubicin to treat metastatic breast cancer. Oncology. 1986; 43(4):205-7.
    View in: PubMed
    Score: 0.004
  68. Trioxifene mesylate in the treatment of advanced breast cancer. Cancer. 1986 Jan 01; 57(1):40-3.
    View in: PubMed
    Score: 0.004
  69. Management of inflammatory carcinoma of the breast. A combined modality approach. Am J Clin Oncol. 1985 Apr; 8(2):134-41.
    View in: PubMed
    Score: 0.004
  70. Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer. 1985 Jan 15; 55(2):341-6.
    View in: PubMed
    Score: 0.004
  71. Induction chemotherapy of breast cancer. Prog Clin Biol Res. 1985; 201:105-16.
    View in: PubMed
    Score: 0.004
  72. The management of locally advanced breast cancer: a combined modality approach. Eur J Cancer Clin Oncol. 1984 Nov; 20(11):1353-61.
    View in: PubMed
    Score: 0.004
  73. Phase II evaluation of vinblastine, methotrexate, and calcium leukovorin rescue in patients with refractory metastatic breast cancer. Cancer. 1983 Mar 01; 51(5):769-72.
    View in: PubMed
    Score: 0.003
  74. Multimodal treatment of locoregionally advanced breast cancer. Cancer. 1983 Mar 01; 51(5):763-8.
    View in: PubMed
    Score: 0.003
  75. Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer. Am J Clin Oncol. 1982 Oct; 5(5):511-4.
    View in: PubMed
    Score: 0.003
  76. Dihydroxyanthracenedione: a promising new drug in the treatment of metastatic breast cancer. Ann Intern Med. 1981 Dec; 95(6):694-7.
    View in: PubMed
    Score: 0.003
  77. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):775-9.
    View in: PubMed
    Score: 0.003
  78. Prognostic value of prechemotherapy skin tests in patients with metastatic breast carcinoma. Cancer. 1981 Mar 15; 47(6):1369-76.
    View in: PubMed
    Score: 0.003
  79. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy. J Surg Oncol. 1981; 18(2):163-72.
    View in: PubMed
    Score: 0.003
  80. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med. 1980 Sep; 93(3):399-406.
    View in: PubMed
    Score: 0.003
  81. A phase II study of peptichemio in advanced breast cancer. Cancer. 1980 May 15; 45(10):2524-8.
    View in: PubMed
    Score: 0.003
  82. Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine. Cancer Treat Rep. 1980 Jan; 64(1):157-9.
    View in: PubMed
    Score: 0.003
  83. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer. J Surg Oncol. 1979 Dec; 12(4):333-41.
    View in: PubMed
    Score: 0.003
  84. Complete remissions in metastatic breast cancer treated with combination drug therapy. Ann Intern Med. 1979 Dec; 91(6):847-52.
    View in: PubMed
    Score: 0.003
  85. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1961-4.
    View in: PubMed
    Score: 0.003
  86. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG. Cancer. 1979 Nov; 44(5):1955-62.
    View in: PubMed
    Score: 0.003
  87. Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):2053-6.
    View in: PubMed
    Score: 0.003
  88. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer. Cancer. 1979 Aug; 44(2):398-405.
    View in: PubMed
    Score: 0.003
  89. Combination chemotherapy with vincristine and methotrexate for advanced refractory breast cancer. Cancer. 1979 Jul; 44(1):32-4.
    View in: PubMed
    Score: 0.003
  90. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG. Cancer. 1979 Apr; 43(4):1225-33.
    View in: PubMed
    Score: 0.003
  91. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole. Cancer. 1979 Mar; 43(3):1112-22.
    View in: PubMed
    Score: 0.003
  92. Electrocardiographic changes after adriamycin chemotherapy. Cancer. 1979 Feb; 43(2):465-71.
    View in: PubMed
    Score: 0.003
  93. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma. J Surg Oncol. 1979; 11(4):325-32.
    View in: PubMed
    Score: 0.003
  94. Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer. Cancer Treat Rep. 1979 Jan; 63(1):77-83.
    View in: PubMed
    Score: 0.003
  95. Spontaneous regression of breast carcinoma. Arch Intern Med. 1978 Nov; 138(11):1734-5.
    View in: PubMed
    Score: 0.003
  96. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Gu?rin. Cancer Treat Rep. 1978 Nov; 62(11):1685-92.
    View in: PubMed
    Score: 0.003
  97. Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma. Cancer Treat Rep. 1978 Oct; 62(10):1565-7.
    View in: PubMed
    Score: 0.003
  98. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer. Cancer. 1978 Apr; 41(4):1235-9.
    View in: PubMed
    Score: 0.002
  99. Chemo immunotherapy of advanced breast cancer with BCG. Recent Results Cancer Res. 1977; (62):143-50.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.